{"protocolSection":{"identificationModule":{"nctId":"NCT02543892","orgStudyIdInfo":{"id":"VAC-040"},"organization":{"fullName":"PATH","class":"OTHER"},"briefTitle":"A Study of a Vaccine for Pneumonia in Adults and Toddlers in Kenya","officialTitle":"Phase 1-2 Safety and Immunogenicity Study of PATH-wSP in Kenyan Adults and Toddlers"},"statusModule":{"statusVerifiedDate":"2018-11","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2016-08-10","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2018-01-04","type":"ACTUAL"},"completionDateStruct":{"date":"2018-01-04","type":"ACTUAL"},"studyFirstSubmitDate":"2015-09-01","studyFirstSubmitQcDate":"2015-09-04","studyFirstPostDateStruct":{"date":"2015-09-07","type":"ESTIMATED"},"resultsFirstSubmitDate":"2018-08-31","resultsFirstSubmitQcDate":"2018-11-26","resultsFirstPostDateStruct":{"date":"2018-11-28","type":"ACTUAL"},"lastUpdateSubmitDate":"2018-11-26","lastUpdatePostDateStruct":{"date":"2018-11-28","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"PATH","class":"OTHER"}},"oversightModule":{"oversightHasDmc":true},"descriptionModule":{"briefSummary":"This study aimed to determine whether PATH-wSP, a vaccine against a germ that causes pneumonia, is safe and induces immune responses in adults and toddlers. The study vaccine was compared to placebo. First adults received 2 injections of a lower dose of the vaccine or placebo, 28 days apart. Since the lower dose was considered safe, a higher dose was tested. Once the safety was established in adults the lower and higher dose was tested in toddlers, starting with the lower dose and then the higher dose.","detailedDescription":"S. pneumoniae whole cell vaccine (SPWCV) is a vaccine candidate made from whole unencapsulated pneumococcal cells and adsorbed to aluminum hydroxide adjuvant (Alum). After adsorption of the Alum to SPWCV, the vaccine is referred to as PATH-wSP. PATH-wSP has been previously tested in Phase 1/2 studies in healthy US adults (VAC-002), and in healthy Kenyan adults and toddlers (VAC-010) and showed a favorable safety, tolerability, and immunogenicity profile. The SPWCV and Alum used in previous Phase 1/2 trials were supplied separately in a two-vial configuration; the SPWCV was manufactured at Walter Reed Army Institute of Research and the Alum at Instituto Butantan. A single-vial formulation of PATH wSP, an adsorbed suspension of SPWCV and Alum, has now been manufactured by PT Bio Farma, Indonesia. The purpose of this study was to assess the safety and tolerability of this new formulation."},"conditionsModule":{"conditions":["Pneumonia"],"keywords":["Vaccine"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE1","PHASE2"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"PREVENTION","maskingInfo":{"masking":"QUADRUPLE","whoMasked":["PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":248,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Adult 0.6mg PATH-wSP","type":"EXPERIMENTAL","description":"Two 0.6 mg doses of PATH-wSP with a 28 day interval between doses","interventionNames":["Biological: PATH-wSP"]},{"label":"Adult Placebo Low Dose","type":"PLACEBO_COMPARATOR","description":"Two injections of normal saline with a 28 day interval between injections","interventionNames":["Biological: Placebo"]},{"label":"Adult 1.0 mg PATH-wSP","type":"EXPERIMENTAL","description":"Two 1 mg doses of PATH-wSP with a 28 day interval between doses","interventionNames":["Biological: PATH-wSP"]},{"label":"Adult Placebo High Dose","type":"PLACEBO_COMPARATOR","description":"Two injections of normal saline with a 28 day interval between injections","interventionNames":["Biological: Placebo"]},{"label":"Toddler 0.6mg PATH-wSP","type":"EXPERIMENTAL","description":"Two 0.6 mg doses of PATH-wSP with a 28 day interval between doses","interventionNames":["Biological: PATH-wSP"]},{"label":"Toddler Placebo Low Dose","type":"PLACEBO_COMPARATOR","description":"Two injections of normal saline with a 28 day interval between injections","interventionNames":["Biological: Placebo"]},{"label":"Toddler 1.0 mg PATH-wSP","type":"EXPERIMENTAL","description":"Two 1 mg doses of PATH-wSP with a 28 day interval between doses","interventionNames":["Biological: PATH-wSP"]},{"label":"Toddler Placebo High Dose","type":"PLACEBO_COMPARATOR","description":"Two injections of normal saline with a 28 day interval between injections","interventionNames":["Biological: Placebo"]}],"interventions":[{"type":"BIOLOGICAL","name":"PATH-wSP","description":"Streptococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide","armGroupLabels":["Adult 0.6mg PATH-wSP","Adult 1.0 mg PATH-wSP","Toddler 0.6mg PATH-wSP","Toddler 1.0 mg PATH-wSP"]},{"type":"BIOLOGICAL","name":"Placebo","description":"Normal Saline","armGroupLabels":["Adult Placebo High Dose","Adult Placebo Low Dose","Toddler Placebo High Dose","Toddler Placebo Low Dose"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Highest Grade of Reactogenicity Events in the Adult Cohort: Vaccination 1","description":"Solicited adverse events (AEs) were referred to as reactogenicity events (REs). Local REs included pain, induration/swelling, and erythema/redness at the injection site for adults; and pain/tenderness, redness, and induration/swelling for toddlers. Solicited systemic REs included cutaneous rash, headache, axillary fever/temperature, fatigue/malaise, and arthralgia/myalgia. Solicited REs were assessed for all subjects during the 60 minutes post-vaccination, daily for the first week, and at the clinic visit 1 week post-vaccination. Within the first week post-vaccination, fieldworkers visited the subject at home daily to assess and record solicited reactogenicity and determine whether the subject needed to be seen by the principal investigator (PI) for any medical condition or issue. Generally, grade 1 was no interference with activity, grade 2 was some interference with activity, and grade 3 was prevents daily activity. Grade 0 is equivalent to no event.","timeFrame":"7 days after the first dose (Day 7)"},{"measure":"Highest Grade of Reactogenicity Events in the Adult Cohort: Vaccination 2","description":"Solicited adverse events (AEs) were referred to as reactogenicity events (REs). Local REs included pain, induration/swelling, and erythema/redness at the injection site for adults; and pain/tenderness, redness, and induration/swelling for toddlers. Solicited systemic REs included cutaneous rash, headache, axillary fever/temperature, fatigue/malaise, and arthralgia/myalgia. Solicited REs were assessed for all subjects during the 60 minutes post-vaccination, daily for the first week, and at the clinic visit 1 week post-vaccination. Within the first week post-vaccination, fieldworkers visited the subject at home daily to assess and record solicited reactogenicity and determine whether the subject needed to be seen by the principal investigator (PI) for any medical condition or issue. Generally, grade 1 was no interference with activity, grade 2 was some interference with activity, and grade 3 was prevents daily activity.","timeFrame":"7 days after the second dose (Day 35)"},{"measure":"Highest Grade of Reactogenicity Events in the Toddler Cohort: Vaccination 1","description":"Solicited adverse events (AEs) were referred to as reactogenicity events (REs). Local REs included pain, induration/swelling, and erythema/redness at the injection site for adults; and pain/tenderness, redness, and induration/swelling for toddlers. Solicited systemic REs included cutaneous rash, axillary fever/temperature, drowsiness, irritability, and decreased appetite. Solicited REs were assessed for all subjects during the 60 minutes post-vaccination, daily for the first week, and at the clinic visit 1 week post-vaccination. Within the first week post-vaccination, fieldworkers visited the subject at home daily to assess and record solicited reactogenicity and determine whether the subject needed to be seen by the PI for any medical condition or issue. Generally, grade 1 was no interference with activity, grade 2 was some interference with activity, and grade 3 was prevents daily activity. Grade 0 is equivalent to no event.","timeFrame":"7 days after the first dose (Day 7)"},{"measure":"Highest Grade of Reactogenicity Events in the Toddler Cohort: Vaccination 2","description":"Solicited adverse events (AEs) were referred to as reactogenicity events (REs). Local REs included pain, induration/swelling, and erythema/redness at the injection site for adults; and pain/tenderness, redness, and induration/swelling for toddlers. Solicited systemic REs included cutaneous rash, axillary fever/temperature, drowsiness, irritability, and decreased appetite. Solicited REs were assessed for all subjects during the 60 minutes post-vaccination, daily for the first week, and at the clinic visit 1 week post-vaccination. Within the first week post-vaccination, fieldworkers visited the subject at home daily to assess and record solicited reactogenicity and determine whether the subject needed to be seen by the PI for any medical condition or issue. Generally, grade 1 was no interference with activity, grade 2 was some interference with activity, and grade 3 was prevents daily activity. Grade 0 is equivalent to no event.","timeFrame":"7 days after the second dose (Day 35)"},{"measure":"Number of Adverse Events (AE), by Relation to Vaccine and Seriousness","description":"Only treatment-emergent adverse events (TEAEs) were included in the analysis; adverse events (AEs) that were not TEAEs were to have been listed.","timeFrame":"112 days"}],"secondaryOutcomes":[{"measure":"Immunoglobulin G (IgG) Antibody Geometric Mean Concentration Against Pneumococcal Proteins","description":"Proteins were measured on the Meso Scale Discovery (MSD) platform using an an electrochemiluminescence detection assay. Units were arbitrary.","timeFrame":"Baseline and 12 weeks after vaccination 2 (Day 0 and Day 112)"},{"measure":"Immunoglobulin G (IgG) Antibody Geometric Mean Fold Change Against Pneumococcal Proteins","description":"Between baseline and 28 days after vaccination 2. Proteins were measured on the Meso Scale Discovery (MSD) platform using an an electrochemiluminescence detection assay.","timeFrame":"Baseline and 12 weeks after vaccination 2 (Day 0 and Day 112)"},{"measure":"Number of Subjects With Immunoglobulin G (IgG) Seroresponse","description":"Between baseline and 28 days after vaccination 2. Proteins were measured on the Meso Scale Discovery (MSD) platform using an an electrochemiluminescence detection assay.","timeFrame":"Baseline and 12 weeks after vaccination 2 (Day 0 and Day 112)"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Healthy adults who are 18 to 40 years old, or toddlers who are 12 to 19 months old.\n* Must provide voluntary written/thumb-printed informed consent\n* Must comply with study requirements and procedures.\n* Must have an identifiable place of residence to allow home visits, and a consistent means of telephone contact\n* Must be resident in the study area with no plans to travel outside the study area during the study\n* Must be willing to not take herbal or other local traditional medications within 28 days of randomization and during the course of the study\n* Adult female subjects must have a negative serum pregnancy test at screening and urine pregnancy test prior to each vaccination\n* Toddlers must have been born full-term, and have a mid-upper arm circumference \\> 11.5 cm at the time of enrollment.\n* Toddlers must have completed their Kenyan infant EPI schedule through 9 months including 1 birth dose of BCG, 3 doses of DTwPHibHep, 3 doses of OPV (birth dose is not required), 3 doses of PCV, and 1 dose of measles vaccine\n\nExclusion Criteria:\n\n* Use of any investigational or nonregistered drug within 90 days of enrollment\n* Use of any potentially hepatotoxic drug\n* Receipt of any licensed vaccine within 14 days of administration of study vaccine.\n* Chronic, clinically significant pulmonary, cardiovascular, hepatobiliary, gastrointestinal, renal, neurological, or hematological functional abnormality or major congenital defects or illness that requires medical therapy, based on medical history or clinical assessment\n* History of anaphylactic shock\n* History of a serious reaction to any prior vaccination or known hypersensitivity to any component of the study vaccines\n* History of immunosuppression or immunodeficiency, inclusive of human immunodeficiency virus (HIV) infection by medical history (including that of an enrolled toddler's mother) or by HIV testing at screening\n* Evidence of active hepatitis infection (B or C) by serologic testing at screening.\n* Any screening laboratory test (chemistry or hematology) or vital sign measurement with toxicity grade ≥ 1\n* Acute illness (moderate or severe) and/or fever (axillary temperature ≥ 37.5°C)\n* Positive test for malaria (blood film) at screening that remains positive post treatment when retested prior to vaccination\n* Disorders that require chronic administration (defined as more than 14 consecutive days) of immunosuppressants or other immune-modifying drugs within the past 6 months prior to the administration of the study vaccine.\n* Administration of immunoglobulins and/or any blood products within the 6 months preceding enrollment in the study\n* Known disturbance of coagulation or other blood disorder (e.g., thalassemia, sickle cell disease, thrombocytopenia, disorders of the lymphocytes, severe anemia at birth) in adult subject or in self/first-degree relative of toddler subject; or receipt of anticoagulants in the past three weeks (aspirin as needed and nonsteroidal anti-inflammatory drugs are acceptable)\n* History of meningitis, seizures or any neurological disorder (all participants) or major psychiatric disorder (adults)\n* Any medical or social condition that in the opinion of the investigator will interfere with the study objectives or pose a risk to the study subject\n* An employee (or first-degree relative of employee) of the Sponsor, the CRO, or any investigator or site personnel\n* Female adult subjects who are pregnant or breast-feeding\n* Adults with a recent history (within the past year) of alcohol or substance abuse.\n* Toddlers who have already received a pentavalent booster (following the primary series).\n* Toddlers with a family history of suspected primary immunodeficiency in first-degree relative.\n* Toddlers who had a sibling die of likely sudden infant death syndrome (SIDS) or die suddenly and without apparent other cause or preceding illness in the first year of life.\n* Toddlers with evidence of a clinically significant congenital abnormality as judged by the PI.\n* Toddlers with evidence of fetal alcohol syndrome or maternal history of alcohol abuse during pregnancy","healthyVolunteers":true,"sex":"ALL","minimumAge":"1 Year","maximumAge":"40 Years","stdAges":["CHILD","ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Anthony Scott, MD","affiliation":"London School of Hygiene and Tropical Medicine","role":"STUDY_CHAIR"}],"locations":[{"facility":"KEMRI-Wellcome Trust Research Programme; Centre for Geographic Medicine Research - Coast","city":"Kilifi","zip":"80108","country":"Kenya","geoPoint":{"lat":-3.63045,"lon":39.84992}}]}},"resultsSection":{"participantFlowModule":{"groups":[{"id":"FG000","title":"Adult 0.6mg PATH-wSP","description":"Two 0.6 mg doses of PATH-wSP with a 28 day interval between doses\n\nPATH-wSP: Streptococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide"},{"id":"FG001","title":"Adult 1.0 mg PATH-wSP","description":"Two 1 mg doses of PATH-wSP with a 28 day interval between doses\n\nPATH-wSP: Streptococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide"},{"id":"FG002","title":"Adult Placebo Low Dose","description":"Two injections of normal saline with a 28 day interval between injections\n\nPlacebo: Normal Saline"},{"id":"FG003","title":"Adult Placebo High Dose","description":"Two injections of normal saline with a 28 day interval between injections\n\nPlacebo: Normal Saline"},{"id":"FG004","title":"Toddler 0.6mg PATH-wSP","description":"Two 0.6 mg doses of PATH-wSP with a 28 day interval between doses\n\nPATH-wSP: Streptococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide"},{"id":"FG005","title":"Toddler 1.0 mg PATH-wSP","description":"Two 1 mg doses of PATH-wSP with a 28 day interval between doses\n\nPATH-wSP: Streptococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide"},{"id":"FG006","title":"Toddler Placebo Low Dose","description":"Two injections of normal saline with a 28 day interval between injections\n\nPlacebo: Normal Saline"},{"id":"FG007","title":"Toddler Placebo High Dose","description":"Two injections of normal saline with a 28 day interval between injections\n\nPlacebo: Normal Saline"}],"periods":[{"title":"Received Vaccination 1","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"12"},{"groupId":"FG001","numSubjects":"12"},{"groupId":"FG002","numSubjects":"12"},{"groupId":"FG003","numSubjects":"12"},{"groupId":"FG004","numSubjects":"50"},{"groupId":"FG005","numSubjects":"50"},{"groupId":"FG006","numSubjects":"50"},{"groupId":"FG007","numSubjects":"50"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"12"},{"groupId":"FG001","numSubjects":"12"},{"groupId":"FG002","numSubjects":"12"},{"groupId":"FG003","numSubjects":"12"},{"groupId":"FG004","numSubjects":"50"},{"groupId":"FG005","numSubjects":"50"},{"groupId":"FG006","numSubjects":"50"},{"groupId":"FG007","numSubjects":"50"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"0"}]}]},{"title":"Received Vaccination 2","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"12"},{"groupId":"FG001","numSubjects":"12"},{"groupId":"FG002","numSubjects":"12"},{"groupId":"FG003","numSubjects":"12"},{"groupId":"FG004","numSubjects":"50"},{"groupId":"FG005","numSubjects":"50"},{"groupId":"FG006","numSubjects":"50"},{"groupId":"FG007","numSubjects":"50"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"11"},{"groupId":"FG001","numSubjects":"11"},{"groupId":"FG002","numSubjects":"12"},{"groupId":"FG003","numSubjects":"12"},{"groupId":"FG004","numSubjects":"50"},{"groupId":"FG005","numSubjects":"49"},{"groupId":"FG006","numSubjects":"50"},{"groupId":"FG007","numSubjects":"49"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"1"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"1"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"1"}]}],"dropWithdraws":[{"type":"Withdrawal by Subject","reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"1"}]},{"type":"Physician Decision","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"1"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"0"}]},{"type":"Adverse Event","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"1"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"0"}]}]},{"title":"Had Immunology Data","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"11"},{"groupId":"FG001","numSubjects":"11"},{"groupId":"FG002","numSubjects":"12"},{"groupId":"FG003","numSubjects":"12"},{"groupId":"FG004","numSubjects":"50"},{"groupId":"FG005","numSubjects":"49"},{"groupId":"FG006","numSubjects":"50"},{"groupId":"FG007","numSubjects":"49"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"11"},{"groupId":"FG001","numSubjects":"11"},{"groupId":"FG002","numSubjects":"12"},{"groupId":"FG003","numSubjects":"12"},{"groupId":"FG004","numSubjects":"50"},{"groupId":"FG005","numSubjects":"49"},{"groupId":"FG006","comment":"Subject received both vaccinations and attended last visit, but withdrew consent afterwards.","numSubjects":"49"},{"groupId":"FG007","numSubjects":"49"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"1"},{"groupId":"FG007","numSubjects":"0"}]}],"dropWithdraws":[{"type":"Withdrawal by Subject","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"1"},{"groupId":"FG007","numSubjects":"0"}]}]}]},"baselineCharacteristicsModule":{"groups":[{"id":"BG000","title":"Adult 0.6mg PATH-wSP","description":"Two 0.6 mg doses of PATH-wSP with a 28 day interval between doses\n\nPATH-wSP: Streptococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide"},{"id":"BG001","title":"Adult 1.0 mg PATH-wSP","description":"Two 1 mg doses of PATH-wSP with a 28 day interval between doses\n\nPATH-wSP: Streptococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide"},{"id":"BG002","title":"Adult Placebo Low Dose","description":"Two injections of normal saline with a 28 day interval between injections\n\nPlacebo: Normal Saline"},{"id":"BG003","title":"Adult Placebo High Dose","description":"Two injections of normal saline with a 28 day interval between injections\n\nPlacebo: Normal Saline"},{"id":"BG004","title":"Toddler 0.6mg PATH-wSP","description":"Two 0.6 mg doses of PATH-wSP with a 28 day interval between doses\n\nPATH-wSP: Streptococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide"},{"id":"BG005","title":"Toddler 1.0 mg PATH-wSP","description":"Two 1 mg doses of PATH-wSP with a 28 day interval between doses\n\nPATH-wSP: Streptococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide"},{"id":"BG006","title":"Toddler Placebo Low Dose","description":"Two injections of normal saline with a 28 day interval between injections\n\nPlacebo: Normal Saline"},{"id":"BG007","title":"Toddler Placebo High Dose","description":"Two injections of normal saline with a 28 day interval between injections\n\nPlacebo: Normal Saline"},{"id":"BG008","title":"Total","description":"Total of all reporting groups"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"12"},{"groupId":"BG001","value":"12"},{"groupId":"BG002","value":"12"},{"groupId":"BG003","value":"12"},{"groupId":"BG004","value":"50"},{"groupId":"BG005","value":"50"},{"groupId":"BG006","value":"50"},{"groupId":"BG007","value":"50"},{"groupId":"BG008","value":"248"}]}],"measures":[{"title":"Age, Continuous","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"years","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"25.7","spread":"7.04"},{"groupId":"BG001","value":"30.8","spread":"5.51"},{"groupId":"BG002","value":"29.5","spread":"6.74"},{"groupId":"BG003","value":"27.6","spread":"6.78"},{"groupId":"BG004","value":"1.4","spread":"0.25"},{"groupId":"BG005","value":"1.4","spread":"0.19"},{"groupId":"BG006","value":"1.3","spread":"0.21"},{"groupId":"BG007","value":"1.4","spread":"0.21"},{"groupId":"BG008","value":"6.6","spread":"11.1"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"5"},{"groupId":"BG003","value":"4"},{"groupId":"BG004","value":"23"},{"groupId":"BG005","value":"29"},{"groupId":"BG006","value":"31"},{"groupId":"BG007","value":"24"},{"groupId":"BG008","value":"125"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"8"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"7"},{"groupId":"BG003","value":"8"},{"groupId":"BG004","value":"27"},{"groupId":"BG005","value":"21"},{"groupId":"BG006","value":"19"},{"groupId":"BG007","value":"26"},{"groupId":"BG008","value":"123"}]}]}]},{"title":"Race (NIH/OMB)","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"American Indian or Alaska Native","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"0"}]},{"title":"Asian","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"0"}]},{"title":"Native Hawaiian or Other Pacific Islander","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"0"}]},{"title":"Black or African American","measurements":[{"groupId":"BG000","value":"12"},{"groupId":"BG001","value":"12"},{"groupId":"BG002","value":"12"},{"groupId":"BG003","value":"12"},{"groupId":"BG004","value":"50"},{"groupId":"BG005","value":"50"},{"groupId":"BG006","value":"50"},{"groupId":"BG007","value":"50"},{"groupId":"BG008","value":"248"}]},{"title":"White","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"0"}]},{"title":"More than one race","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"0"}]},{"title":"Unknown or Not Reported","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"0"}]}]}]},{"title":"Ethnic Group","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Chonyi","measurements":[{"groupId":"BG000","value":"11"},{"groupId":"BG001","value":"8"},{"groupId":"BG002","value":"6"},{"groupId":"BG003","value":"7"},{"groupId":"BG004","value":"38"},{"groupId":"BG005","value":"45"},{"groupId":"BG006","value":"40"},{"groupId":"BG007","value":"42"},{"groupId":"BG008","value":"197"}]},{"title":"Giriama","measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"4"},{"groupId":"BG003","value":"2"},{"groupId":"BG004","value":"9"},{"groupId":"BG005","value":"5"},{"groupId":"BG006","value":"9"},{"groupId":"BG007","value":"5"},{"groupId":"BG008","value":"37"}]},{"title":"Luo","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"1"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"1"}]},{"title":"Other","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"2"},{"groupId":"BG003","value":"3"},{"groupId":"BG004","value":"2"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"1"},{"groupId":"BG007","value":"3"},{"groupId":"BG008","value":"13"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Highest Grade of Reactogenicity Events in the Adult Cohort: Vaccination 1","description":"Solicited adverse events (AEs) were referred to as reactogenicity events (REs). Local REs included pain, induration/swelling, and erythema/redness at the injection site for adults; and pain/tenderness, redness, and induration/swelling for toddlers. Solicited systemic REs included cutaneous rash, headache, axillary fever/temperature, fatigue/malaise, and arthralgia/myalgia. Solicited REs were assessed for all subjects during the 60 minutes post-vaccination, daily for the first week, and at the clinic visit 1 week post-vaccination. Within the first week post-vaccination, fieldworkers visited the subject at home daily to assess and record solicited reactogenicity and determine whether the subject needed to be seen by the principal investigator (PI) for any medical condition or issue. Generally, grade 1 was no interference with activity, grade 2 was some interference with activity, and grade 3 was prevents daily activity. Grade 0 is equivalent to no event.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"7 days after the first dose (Day 7)","groups":[{"id":"OG000","title":"Adult 0.6mg PATH-wSP","description":"Two 0.6 mg doses of PATH-wSP with a 28 day interval between doses\n\nPATH-wSP: Streptococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide"},{"id":"OG001","title":"Adult 1.0 mg PATH-wSP","description":"Two 1 mg doses of PATH-wSP with a 28 day interval between doses\n\nPATH-wSP: Streptococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide"},{"id":"OG002","title":"Adult Placebo","description":"Two injections of normal saline with a 28 day interval between injections\n\nPlacebo: Normal Saline"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"12"},{"groupId":"OG002","value":"24"}]}],"classes":[{"title":"Cutaneous Rash","categories":[{"title":"Grade 0","measurements":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"12"},{"groupId":"OG002","value":"22"}]},{"title":"Grade 1","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]},{"title":"Grade 2","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]},{"title":"Grade 3","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Headache","categories":[{"title":"Grade 0","measurements":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"19"}]},{"title":"Grade 1","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"5"}]},{"title":"Grade 2","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]},{"title":"Grade 3","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Fatigue/Malaise","categories":[{"title":"Grade 0","measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"21"}]},{"title":"Grade 1","measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"2"}]},{"title":"Grade 2","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]},{"title":"Grade 3","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Myalgia","categories":[{"title":"Grade 0","measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"23"}]},{"title":"Grade 1","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"0"}]},{"title":"Grade 2","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]},{"title":"Grade 3","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Arthralgia","categories":[{"title":"Grade 0","measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"23"}]},{"title":"Grade 1","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"}]},{"title":"Grade 2","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]},{"title":"Grade 3","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Pain at Injection Site","categories":[{"title":"Grade 0","measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"17"}]},{"title":"Grade 1","measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"7"}]},{"title":"Grade 2","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"}]},{"title":"Grade 3","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Swelling/Hardness at injection site","categories":[{"title":"Grade 0","measurements":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"24"}]},{"title":"Grade 1","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]},{"title":"Grade 2","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"}]},{"title":"Grade 3","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]}]},{"type":"PRIMARY","title":"Highest Grade of Reactogenicity Events in the Adult Cohort: Vaccination 2","description":"Solicited adverse events (AEs) were referred to as reactogenicity events (REs). Local REs included pain, induration/swelling, and erythema/redness at the injection site for adults; and pain/tenderness, redness, and induration/swelling for toddlers. Solicited systemic REs included cutaneous rash, headache, axillary fever/temperature, fatigue/malaise, and arthralgia/myalgia. Solicited REs were assessed for all subjects during the 60 minutes post-vaccination, daily for the first week, and at the clinic visit 1 week post-vaccination. Within the first week post-vaccination, fieldworkers visited the subject at home daily to assess and record solicited reactogenicity and determine whether the subject needed to be seen by the principal investigator (PI) for any medical condition or issue. Generally, grade 1 was no interference with activity, grade 2 was some interference with activity, and grade 3 was prevents daily activity.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"7 days after the second dose (Day 35)","groups":[{"id":"OG000","title":"Adult 0.6mg PATH-wSP","description":"Two 0.6 mg doses of PATH-wSP with a 28 day interval between doses\n\nPATH-wSP: Streptococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide"},{"id":"OG001","title":"Adult 1.0 mg PATH-wSP","description":"Two 1 mg doses of PATH-wSP with a 28 day interval between doses\n\nPATH-wSP: Streptococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide"},{"id":"OG002","title":"Adult Placebo","description":"Two injections of normal saline with a 28 day interval between injections\n\nPlacebo: Normal Saline"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"24"}]}],"classes":[{"title":"Cutaneous Rash","categories":[{"title":"Grade 0","measurements":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"22"}]},{"title":"Grade 1","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"}]},{"title":"Grade 2","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]},{"title":"Grade 3","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Headache","categories":[{"title":"Grade 0","measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"19"}]},{"title":"Grade 1","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"5"}]},{"title":"Grade 2","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]},{"title":"Grade 3","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Fatigue/Malaise","categories":[{"title":"Grade 0","measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"22"}]},{"title":"Grade 1","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]},{"title":"Grade 2","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"}]},{"title":"Grade 3","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Myalgia","categories":[{"title":"Grade 0","measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"24"}]},{"title":"Grade 1","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]},{"title":"Grade 2","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]},{"title":"Grade 3","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Arthralgia","categories":[{"title":"Grade 0","measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"22"}]},{"title":"Grade 1","measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]},{"title":"Grade 2","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]},{"title":"Grade 3","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Pain at Injection Site","categories":[{"title":"Grade 0","measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"15"}]},{"title":"Grade 1","measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"8"}]},{"title":"Grade 2","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]},{"title":"Grade 3","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Swelling/Hardness at injection site","categories":[{"title":"Grade 0","measurements":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"24"}]},{"title":"Grade 1","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]},{"title":"Grade 2","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]},{"title":"Grade 3","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Temperature","categories":[{"title":"Grade 0","measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"24"}]},{"title":"Grade 1","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]},{"title":"Grade 2","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]},{"title":"Grade 3","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]}]},{"type":"PRIMARY","title":"Highest Grade of Reactogenicity Events in the Toddler Cohort: Vaccination 1","description":"Solicited adverse events (AEs) were referred to as reactogenicity events (REs). Local REs included pain, induration/swelling, and erythema/redness at the injection site for adults; and pain/tenderness, redness, and induration/swelling for toddlers. Solicited systemic REs included cutaneous rash, axillary fever/temperature, drowsiness, irritability, and decreased appetite. Solicited REs were assessed for all subjects during the 60 minutes post-vaccination, daily for the first week, and at the clinic visit 1 week post-vaccination. Within the first week post-vaccination, fieldworkers visited the subject at home daily to assess and record solicited reactogenicity and determine whether the subject needed to be seen by the PI for any medical condition or issue. Generally, grade 1 was no interference with activity, grade 2 was some interference with activity, and grade 3 was prevents daily activity. Grade 0 is equivalent to no event.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"7 days after the first dose (Day 7)","groups":[{"id":"OG000","title":"Toddler 0.6mg PATH-wSP","description":"Two 0.6 mg doses of PATH-wSP with a 28 day interval between doses\n\nPATH-wSP: Streptococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide"},{"id":"OG001","title":"Toddler 1.0 mg PATH-wSP","description":"Two 1 mg doses of PATH-wSP with a 28 day interval between doses\n\nPATH-wSP: Streptococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide"},{"id":"OG002","title":"Toddler Placebo","description":"Two injections of normal saline with a 28 day interval between injections\n\nPlacebo: Normal Saline"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"50"},{"groupId":"OG001","value":"50"},{"groupId":"OG002","value":"100"}]}],"classes":[{"title":"Temperature","categories":[{"title":"Grade 0","measurements":[{"groupId":"OG000","value":"43"},{"groupId":"OG001","value":"47"},{"groupId":"OG002","value":"93"}]},{"title":"Grade 1","measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"6"}]},{"title":"Grade 2","measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]},{"title":"Grade 3","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Cutaneous Rash","categories":[{"title":"Grade 0","measurements":[{"groupId":"OG000","value":"46"},{"groupId":"OG001","value":"44"},{"groupId":"OG002","value":"91"}]},{"title":"Grade 1","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"7"}]},{"title":"Grade 2","measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"2"}]},{"title":"Grade 3","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Irritability","categories":[{"title":"Grade 0","measurements":[{"groupId":"OG000","value":"42"},{"groupId":"OG001","value":"45"},{"groupId":"OG002","value":"97"}]},{"title":"Grade 1","measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"3"}]},{"title":"Grade 2","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]},{"title":"Grade 3","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Drowsiness","categories":[{"title":"Grade 0","measurements":[{"groupId":"OG000","value":"50"},{"groupId":"OG001","value":"49"},{"groupId":"OG002","value":"98"}]},{"title":"Grade 1","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"}]},{"title":"Grade 2","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]},{"title":"Grade 3","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Loss of appetite","categories":[{"title":"Grade 0","measurements":[{"groupId":"OG000","value":"41"},{"groupId":"OG001","value":"48"},{"groupId":"OG002","value":"95"}]},{"title":"Grade 1","measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"5"}]},{"title":"Grade 2","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]},{"title":"Grade 3","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Tenderness at injection site","categories":[{"title":"Grade 0","measurements":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"94"}]},{"title":"Grade 1","measurements":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"6"}]},{"title":"Grade 2","measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]},{"title":"Grade 3","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Redness at injection site","categories":[{"title":"Grade 0","measurements":[{"groupId":"OG000","value":"48"},{"groupId":"OG001","value":"46"},{"groupId":"OG002","value":"94"}]},{"title":"Grade 1","measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"6"}]},{"title":"Grade 2","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]},{"title":"Grade 3","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Swelling/hardness at injection site","categories":[{"title":"Grade 0","measurements":[{"groupId":"OG000","value":"46"},{"groupId":"OG001","value":"45"},{"groupId":"OG002","value":"99"}]},{"title":"Grade 1","measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"1"}]},{"title":"Grade 2","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]},{"title":"Grade 3","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]}]},{"type":"PRIMARY","title":"Highest Grade of Reactogenicity Events in the Toddler Cohort: Vaccination 2","description":"Solicited adverse events (AEs) were referred to as reactogenicity events (REs). Local REs included pain, induration/swelling, and erythema/redness at the injection site for adults; and pain/tenderness, redness, and induration/swelling for toddlers. Solicited systemic REs included cutaneous rash, axillary fever/temperature, drowsiness, irritability, and decreased appetite. Solicited REs were assessed for all subjects during the 60 minutes post-vaccination, daily for the first week, and at the clinic visit 1 week post-vaccination. Within the first week post-vaccination, fieldworkers visited the subject at home daily to assess and record solicited reactogenicity and determine whether the subject needed to be seen by the PI for any medical condition or issue. Generally, grade 1 was no interference with activity, grade 2 was some interference with activity, and grade 3 was prevents daily activity. Grade 0 is equivalent to no event.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"7 days after the second dose (Day 35)","groups":[{"id":"OG000","title":"Toddler 0.6mg PATH-wSP","description":"Two 0.6 mg doses of PATH-wSP with a 28 day interval between doses\n\nPATH-wSP: Streptococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide"},{"id":"OG001","title":"Toddler 1.0 mg PATH-wSP","description":"Two 1 mg doses of PATH-wSP with a 28 day interval between doses\n\nPATH-wSP: Streptococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide"},{"id":"OG002","title":"Toddler Placebo","description":"Two injections of normal saline with a 28 day interval between injections\n\nPlacebo: Normal Saline"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"50"},{"groupId":"OG001","value":"50"},{"groupId":"OG002","value":"100"}]}],"classes":[{"title":"Temperature","categories":[{"title":"Grade 0","measurements":[{"groupId":"OG000","value":"42"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"80"}]},{"title":"Grade 1","measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"11"}]},{"title":"Grade 2","measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"8"}]},{"title":"Grade 3","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}]},{"title":"Cutaneous Rash","categories":[{"title":"Grade 0","measurements":[{"groupId":"OG000","value":"45"},{"groupId":"OG001","value":"46"},{"groupId":"OG002","value":"93"}]},{"title":"Grade 1","measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"6"}]},{"title":"Grade 2","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]},{"title":"Grade 3","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Irritability","categories":[{"title":"Grade 0","measurements":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"61"}]},{"title":"Grade 1","measurements":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"17"},{"groupId":"OG002","value":"36"}]},{"title":"Grade 2","measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"3"}]},{"title":"Grade 3","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Drowsiness","categories":[{"title":"Grade 0","measurements":[{"groupId":"OG000","value":"48"},{"groupId":"OG001","value":"49"},{"groupId":"OG002","value":"89"}]},{"title":"Grade 1","measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"9"}]},{"title":"Grade 2","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"}]},{"title":"Grade 3","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Loss of appetite","categories":[{"title":"Grade 0","measurements":[{"groupId":"OG000","value":"36"},{"groupId":"OG001","value":"36"},{"groupId":"OG002","value":"78"}]},{"title":"Grade 1","measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"14"},{"groupId":"OG002","value":"20"}]},{"title":"Grade 2","measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"}]},{"title":"Grade 3","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Tenderness at injection site","categories":[{"title":"Grade 0","measurements":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"36"},{"groupId":"OG002","value":"75"}]},{"title":"Grade 1","measurements":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"12"},{"groupId":"OG002","value":"21"}]},{"title":"Grade 2","measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"2"}]},{"title":"Grade 3","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"}]}]},{"title":"Redness at injection site","categories":[{"title":"Grade 0","measurements":[{"groupId":"OG000","value":"46"},{"groupId":"OG001","value":"49"},{"groupId":"OG002","value":"97"}]},{"title":"Grade 1","measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"3"}]},{"title":"Grade 2","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]},{"title":"Grade 3","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Swelling/hardness at injection site","categories":[{"title":"Grade 0","measurements":[{"groupId":"OG000","value":"47"},{"groupId":"OG001","value":"46"},{"groupId":"OG002","value":"93"}]},{"title":"Grade 1","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"4"}]},{"title":"Grade 2","measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"3"}]},{"title":"Grade 3","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]}]},{"type":"SECONDARY","title":"Immunoglobulin G (IgG) Antibody Geometric Mean Concentration Against Pneumococcal Proteins","description":"Proteins were measured on the Meso Scale Discovery (MSD) platform using an an electrochemiluminescence detection assay. Units were arbitrary.","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"arbitrary units","timeFrame":"Baseline and 12 weeks after vaccination 2 (Day 0 and Day 112)","groups":[{"id":"OG000","title":"Adult 0.6mg PATH-wSP","description":"Two 0.6 mg doses of PATH-wSP with a 28 day interval between doses\n\nPATH-wSP: Streptococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide"},{"id":"OG001","title":"Adult 1.0 mg PATH-wSP","description":"Two 1 mg doses of PATH-wSP with a 28 day interval between doses\n\nPATH-wSP: Streptococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide"},{"id":"OG002","title":"Adult Placebo Low Dose","description":"Two injections of normal saline with a 28 day interval between injections\n\nPlacebo: Normal Saline"},{"id":"OG003","title":"Adult Placebo High Dose","description":"Two injections of normal saline with a 28 day interval between injections\n\nPlacebo: Normal Saline"},{"id":"OG004","title":"Toddler 0.6mg PATH-wSP","description":"Two 0.6 mg doses of PATH-wSP with a 28 day interval between doses\n\nPATH-wSP: Streptococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide"},{"id":"OG005","title":"Toddler 1.0 mg PATH-wSP","description":"Two 1 mg doses of PATH-wSP with a 28 day interval between doses\n\nPATH-wSP: Streptococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide"},{"id":"OG006","title":"Toddler Placebo Low Dose","description":"Two injections of normal saline with a 28 day interval between injections\n\nPlacebo: Normal Saline"},{"id":"OG007","title":"Toddler Placebo High Dose","description":"Two injections of normal saline with a 28 day interval between injections\n\nPlacebo: Normal Saline"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"12"},{"groupId":"OG003","value":"12"},{"groupId":"OG004","value":"50"},{"groupId":"OG005","value":"49"},{"groupId":"OG006","value":"49"},{"groupId":"OG007","value":"49"}]}],"classes":[{"title":"L460D: Baseline","categories":[{"measurements":[{"groupId":"OG000","value":"642.5","lowerLimit":"370.6","upperLimit":"1113.8"},{"groupId":"OG001","value":"804.6","lowerLimit":"462.2","upperLimit":"1400.7"},{"groupId":"OG002","value":"614.4","lowerLimit":"484.5","upperLimit":"779.2"},{"groupId":"OG003","value":"1022.3","lowerLimit":"755.4","upperLimit":"1383.5"},{"groupId":"OG004","value":"267.7","lowerLimit":"199.2","upperLimit":"359.6"},{"groupId":"OG005","value":"326.8","lowerLimit":"258.5","upperLimit":"413.1"},{"groupId":"OG006","value":"197.4","lowerLimit":"158.2","upperLimit":"246.4"},{"groupId":"OG007","value":"330.6","lowerLimit":"253.9","upperLimit":"430.5"}]}]},{"title":"L460D: Post-vaccination 2","categories":[{"measurements":[{"groupId":"OG000","value":"1004.1","lowerLimit":"608.8","upperLimit":"1656.1"},{"groupId":"OG001","value":"1294.2","lowerLimit":"781.3","upperLimit":"2143.7"},{"groupId":"OG002","value":"620.3","lowerLimit":"455.0","upperLimit":"845.6"},{"groupId":"OG003","value":"943.0","lowerLimit":"658.4","upperLimit":"1350.6"},{"groupId":"OG004","value":"422.1","lowerLimit":"313.0","upperLimit":"569.1"},{"groupId":"OG005","value":"563.6","lowerLimit":"442.0","upperLimit":"718.7"},{"groupId":"OG006","value":"262.3","lowerLimit":"206.6","upperLimit":"332.9"},{"groupId":"OG007","value":"389.6","lowerLimit":"294.7","upperLimit":"515.2"}]}]},{"title":"PspA-Fam1: Baseline","categories":[{"measurements":[{"groupId":"OG000","value":"1555.7","lowerLimit":"791.5","upperLimit":"3057.8"},{"groupId":"OG001","value":"1342.1","lowerLimit":"689.9","upperLimit":"2610.7"},{"groupId":"OG002","value":"2145.3","lowerLimit":"1476.3","upperLimit":"3117.4"},{"groupId":"OG003","value":"2837.2","lowerLimit":"1792.5","upperLimit":"4490.7"},{"groupId":"OG004","value":"197","lowerLimit":"123.2","upperLimit":"315.1"},{"groupId":"OG005","value":"358","lowerLimit":"264.0","upperLimit":"485.4"},{"groupId":"OG006","value":"230.3","lowerLimit":"164.4","upperLimit":"322.6"},{"groupId":"OG007","value":"414.4","lowerLimit":"278.1","upperLimit":"617.4"}]}]},{"title":"PspA-Fam1: Post-vaccination 2","categories":[{"measurements":[{"groupId":"OG000","value":"3344.5","lowerLimit":"1868.9","upperLimit":"5985.2"},{"groupId":"OG001","value":"2684.4","lowerLimit":"1475.7","upperLimit":"4883.1"},{"groupId":"OG002","value":"2071.8","lowerLimit":"1345.9","upperLimit":"3189.3"},{"groupId":"OG003","value":"2588.5","lowerLimit":"1558.8","upperLimit":"4298.5"},{"groupId":"OG004","value":"326.2","lowerLimit":"211.7","upperLimit":"502.6"},{"groupId":"OG005","value":"593.8","lowerLimit":"433.9","upperLimit":"812.6"},{"groupId":"OG006","value":"315.1","lowerLimit":"231.5","upperLimit":"429.0"},{"groupId":"OG007","value":"560.4","lowerLimit":"376.9","upperLimit":"833.3"}]}]},{"title":"PhtD: Baseline","categories":[{"measurements":[{"groupId":"OG000","value":"736.6","lowerLimit":"441.9","upperLimit":"1227.6"},{"groupId":"OG001","value":"942.3","lowerLimit":"506.3","upperLimit":"1754.0"},{"groupId":"OG002","value":"655.7","lowerLimit":"453.0","upperLimit":"949.1"},{"groupId":"OG003","value":"619.5","lowerLimit":"456.2","upperLimit":"841.4"},{"groupId":"OG004","value":"671.3","lowerLimit":"498.1","upperLimit":"904.6"},{"groupId":"OG005","value":"713.2","lowerLimit":"537.6","upperLimit":"946.3"},{"groupId":"OG006","value":"644.1","lowerLimit":"473.1","upperLimit":"876.7"},{"groupId":"OG007","value":"775.8","lowerLimit":"563.6","upperLimit":"1068.0"}]}]},{"title":"PhtD: Post-vaccination 2","categories":[{"measurements":[{"groupId":"OG000","value":"842.5","lowerLimit":"497.8","upperLimit":"1426.0"},{"groupId":"OG001","value":"923.3","lowerLimit":"530.6","upperLimit":"1606.6"},{"groupId":"OG002","value":"663.8","lowerLimit":"451.4","upperLimit":"976.2"},{"groupId":"OG003","value":"592","lowerLimit":"422.0","upperLimit":"830.6"},{"groupId":"OG004","value":"870.3","lowerLimit":"655.2","upperLimit":"1156.1"},{"groupId":"OG005","value":"1064.5","lowerLimit":"826.7","upperLimit":"1370.9"},{"groupId":"OG006","value":"776.3","lowerLimit":"595.7","upperLimit":"1011.8"},{"groupId":"OG007","value":"922.7","lowerLimit":"695.7","upperLimit":"1223.6"}]}]},{"title":"BCH0785: Baseline","categories":[{"measurements":[{"groupId":"OG000","value":"593.8","lowerLimit":"349.4","upperLimit":"1008.9"},{"groupId":"OG001","value":"562.3","lowerLimit":"299.5","upperLimit":"1055.7"},{"groupId":"OG002","value":"1214.5","lowerLimit":"729.7","upperLimit":"2021.3"},{"groupId":"OG003","value":"790.1","lowerLimit":"425.3","upperLimit":"1467.5"},{"groupId":"OG004","value":"287.4","lowerLimit":"208.0","upperLimit":"397.1"},{"groupId":"OG005","value":"389.3","lowerLimit":"288.8","upperLimit":"524.9"},{"groupId":"OG006","value":"237.1","lowerLimit":"168.9","upperLimit":"332.7"},{"groupId":"OG007","value":"346.6","lowerLimit":"246.7","upperLimit":"487.1"}]}]},{"title":"BCH0785: Post-vaccination 2","categories":[{"measurements":[{"groupId":"OG000","value":"713.5","lowerLimit":"410.0","upperLimit":"1241.6"},{"groupId":"OG001","value":"640.6","lowerLimit":"383.3","upperLimit":"1070.8"},{"groupId":"OG002","value":"1205","lowerLimit":"730.8","upperLimit":"1986.9"},{"groupId":"OG003","value":"747.9","lowerLimit":"421.2","upperLimit":"1328.2"},{"groupId":"OG004","value":"398","lowerLimit":"284.8","upperLimit":"556.1"},{"groupId":"OG005","value":"627.8","lowerLimit":"467.7","upperLimit":"842.7"},{"groupId":"OG006","value":"301.8","lowerLimit":"219.1","upperLimit":"415.8"},{"groupId":"OG007","value":"367.4","lowerLimit":"261.9","upperLimit":"515.2"}]}]},{"title":"StkP: Baseline","categories":[{"measurements":[{"groupId":"OG000","value":"524.6","lowerLimit":"255.5","upperLimit":"1076.8"},{"groupId":"OG001","value":"917.6","lowerLimit":"484.9","upperLimit":"1736.2"},{"groupId":"OG002","value":"1270.6","lowerLimit":"819.5","upperLimit":"1970.0"},{"groupId":"OG003","value":"973.3","lowerLimit":"539.9","upperLimit":"1754.7"},{"groupId":"OG004","value":"192","lowerLimit":"136.8","upperLimit":"269.5"},{"groupId":"OG005","value":"218.9","lowerLimit":"160.4","upperLimit":"298.8"},{"groupId":"OG006","value":"153.6","lowerLimit":"113.1","upperLimit":"208.6"},{"groupId":"OG007","value":"197","lowerLimit":"141.8","upperLimit":"273.8"}]}]},{"title":"StkP: Post-vaccination 2","categories":[{"measurements":[{"groupId":"OG000","value":"701.1","lowerLimit":"343.2","upperLimit":"1432.3"},{"groupId":"OG001","value":"1209.4","lowerLimit":"729.7","upperLimit":"2004.3"},{"groupId":"OG002","value":"1329.5","lowerLimit":"859.3","upperLimit":"2056.9"},{"groupId":"OG003","value":"907.7","lowerLimit":"512.9","upperLimit":"1606.2"},{"groupId":"OG004","value":"346","lowerLimit":"245.4","upperLimit":"487.8"},{"groupId":"OG005","value":"409","lowerLimit":"309.3","upperLimit":"540.9"},{"groupId":"OG006","value":"199.1","lowerLimit":"147.2","upperLimit":"269.3"},{"groupId":"OG007","value":"211.6","lowerLimit":"152.0","upperLimit":"294.6"}]}]},{"title":"PcpA: Baseline","categories":[{"measurements":[{"groupId":"OG000","value":"1099.7","lowerLimit":"629.2","upperLimit":"1922.2"},{"groupId":"OG001","value":"967","lowerLimit":"536.3","upperLimit":"1743.6"},{"groupId":"OG002","value":"1240.7","lowerLimit":"874.6","upperLimit":"1760.1"},{"groupId":"OG003","value":"1053.8","lowerLimit":"784.5","upperLimit":"1415.6"},{"groupId":"OG004","value":"505.8","lowerLimit":"324.9","upperLimit":"787.4"},{"groupId":"OG005","value":"431.9","lowerLimit":"286.1","upperLimit":"652.0"},{"groupId":"OG006","value":"635.4","lowerLimit":"398.9","upperLimit":"1011.9"},{"groupId":"OG007","value":"506.1","lowerLimit":"322.7","upperLimit":"793.8"}]}]},{"title":"PcpA: Post-vaccination 2","categories":[{"measurements":[{"groupId":"OG000","value":"1094.6","lowerLimit":"608.8","upperLimit":"1968.0"},{"groupId":"OG001","value":"820.8","lowerLimit":"499.0","upperLimit":"1350.0"},{"groupId":"OG002","value":"1259.7","lowerLimit":"870.2","upperLimit":"1823.6"},{"groupId":"OG003","value":"972.3","lowerLimit":"741.6","upperLimit":"1274.9"},{"groupId":"OG004","value":"611.3","lowerLimit":"395.0","upperLimit":"946.0"},{"groupId":"OG005","value":"580.6","lowerLimit":"378.2","upperLimit":"891.5"},{"groupId":"OG006","value":"778.3","lowerLimit":"489.2","upperLimit":"1238.4"},{"groupId":"OG007","value":"737.5","lowerLimit":"493.1","upperLimit":"1102.8"}]}]},{"title":"SPWCV: Baseline","categories":[{"measurements":[{"groupId":"OG000","value":"938.2","lowerLimit":"787.3","upperLimit":"1118.1"},{"groupId":"OG001","value":"886.3","lowerLimit":"618.9","upperLimit":"1269.3"},{"groupId":"OG002","value":"893.5","lowerLimit":"792.2","upperLimit":"1007.7"},{"groupId":"OG003","value":"742","lowerLimit":"587.7","upperLimit":"936.8"},{"groupId":"OG004","value":"495.2","lowerLimit":"433.5","upperLimit":"565.8"},{"groupId":"OG005","value":"544.9","lowerLimit":"463.3","upperLimit":"640.8"},{"groupId":"OG006","value":"488.3","lowerLimit":"429.7","upperLimit":"554.9"},{"groupId":"OG007","value":"590.8","lowerLimit":"516.6","upperLimit":"675.7"}]}]},{"title":"SPWCV: Post-vaccination 2","categories":[{"measurements":[{"groupId":"OG000","value":"1042.2","lowerLimit":"853.0","upperLimit":"1273.3"},{"groupId":"OG001","value":"954.9","lowerLimit":"714.7","upperLimit":"1275.9"},{"groupId":"OG002","value":"930.6","lowerLimit":"785.9","upperLimit":"1101.9"},{"groupId":"OG003","value":"698.9","lowerLimit":"562.7","upperLimit":"868.1"},{"groupId":"OG004","value":"636.8","lowerLimit":"555.1","upperLimit":"730.5"},{"groupId":"OG005","value":"688.8","lowerLimit":"605.0","upperLimit":"784.3"},{"groupId":"OG006","value":"562.1","lowerLimit":"499.8","upperLimit":"632.2"},{"groupId":"OG007","value":"654.5","lowerLimit":"570.9","upperLimit":"750.4"}]}]},{"title":"PiuA: Baseline","categories":[{"measurements":[{"groupId":"OG000","value":"659.7","lowerLimit":"372.6","upperLimit":"1167.9"},{"groupId":"OG001","value":"796.1","lowerLimit":"509.9","upperLimit":"1243.0"},{"groupId":"OG002","value":"1554.8","lowerLimit":"848.3","upperLimit":"2849.5"},{"groupId":"OG003","value":"1223.9","lowerLimit":"625.0","upperLimit":"2396.6"},{"groupId":"OG004","value":"811.6","lowerLimit":"638.3","upperLimit":"1032.0"},{"groupId":"OG005","value":"917.7","lowerLimit":"735.1","upperLimit":"1145.7"},{"groupId":"OG006","value":"665.4","lowerLimit":"507.6","upperLimit":"872.2"},{"groupId":"OG007","value":"888","lowerLimit":"677.2","upperLimit":"1164.5"}]}]},{"title":"PiuA: Post-vaccination 2","categories":[{"measurements":[{"groupId":"OG000","value":"1001.9","lowerLimit":"496.4","upperLimit":"2022.1"},{"groupId":"OG001","value":"1049.7","lowerLimit":"655.9","upperLimit":"1680.0"},{"groupId":"OG002","value":"1540.4","lowerLimit":"843.2","upperLimit":"2813.9"},{"groupId":"OG003","value":"1214.3","lowerLimit":"621.0","upperLimit":"2374.4"},{"groupId":"OG004","value":"1091.9","lowerLimit":"857.6","upperLimit":"1390.3"},{"groupId":"OG005","value":"1343.2","lowerLimit":"1044.9","upperLimit":"1726.6"},{"groupId":"OG006","value":"809","lowerLimit":"639.0","upperLimit":"1024.4"},{"groupId":"OG007","value":"899","lowerLimit":"681.2","upperLimit":"1186.4"}]}]},{"title":"PiaA: Baseline","categories":[{"measurements":[{"groupId":"OG000","value":"1313.4","lowerLimit":"674.9","upperLimit":"2556.0"},{"groupId":"OG001","value":"1462.5","lowerLimit":"788.2","upperLimit":"2713.8"},{"groupId":"OG002","value":"1620.3","lowerLimit":"1061.7","upperLimit":"2472.9"},{"groupId":"OG003","value":"1611.4","lowerLimit":"1027.4","upperLimit":"2527.5"},{"groupId":"OG004","value":"560.6","lowerLimit":"404.0","upperLimit":"778.0"},{"groupId":"OG005","value":"662.8","lowerLimit":"527.2","upperLimit":"833.1"},{"groupId":"OG006","value":"571.4","lowerLimit":"431.4","upperLimit":"756.8"},{"groupId":"OG007","value":"626.5","lowerLimit":"473.7","upperLimit":"828.4"}]}]},{"title":"PiaA: Post-vaccination 2","categories":[{"measurements":[{"groupId":"OG000","value":"1768.8","lowerLimit":"850.6","upperLimit":"3678.1"},{"groupId":"OG001","value":"1802.5","lowerLimit":"1036.0","upperLimit":"3136.3"},{"groupId":"OG002","value":"1540","lowerLimit":"958.0","upperLimit":"2475.5"},{"groupId":"OG003","value":"1638.8","lowerLimit":"1018.4","upperLimit":"2636.9"},{"groupId":"OG004","value":"743.6","lowerLimit":"537.3","upperLimit":"1029.1"},{"groupId":"OG005","value":"904.3","lowerLimit":"703.5","upperLimit":"1162.2"},{"groupId":"OG006","value":"647.6","lowerLimit":"505.0","upperLimit":"830.4"},{"groupId":"OG007","value":"640.5","lowerLimit":"484.1","upperLimit":"847.4"}]}]}]},{"type":"SECONDARY","title":"Immunoglobulin G (IgG) Antibody Geometric Mean Fold Change Against Pneumococcal Proteins","description":"Between baseline and 28 days after vaccination 2. Proteins were measured on the Meso Scale Discovery (MSD) platform using an an electrochemiluminescence detection assay.","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"fold change","timeFrame":"Baseline and 12 weeks after vaccination 2 (Day 0 and Day 112)","groups":[{"id":"OG000","title":"Adult 0.6mg PATH-wSP","description":"Two 0.6 mg doses of PATH-wSP with a 28 day interval between doses\n\nPATH-wSP: Streptococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide"},{"id":"OG001","title":"Adult 1.0 mg PATH-wSP","description":"Two 1 mg doses of PATH-wSP with a 28 day interval between doses\n\nPATH-wSP: Streptococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide"},{"id":"OG002","title":"Adult Placebo","description":"Two injections of normal saline with a 28 day interval between injections\n\nPlacebo: Normal Saline"},{"id":"OG003","title":"Toddler 0.6mg PATH-wSP","description":"Two 0.6 mg doses of PATH-wSP with a 28 day interval between doses\n\nPATH-wSP: Streptococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide"},{"id":"OG004","title":"Toddler 1.0 mg PATH-wSP","description":"Two 1 mg doses of PATH-wSP with a 28 day interval between doses\n\nPATH-wSP: Streptococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide"},{"id":"OG005","title":"Toddler Placebo","description":"Two injections of normal saline with a 28 day interval between injections\n\nPlacebo: Normal Saline"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"24"},{"groupId":"OG003","value":"50"},{"groupId":"OG004","value":"49"},{"groupId":"OG005","value":"98"}]}],"classes":[{"title":"L460D","categories":[{"measurements":[{"groupId":"OG000","value":"1.56","lowerLimit":"1.28","upperLimit":"1.91"},{"groupId":"OG001","value":"1.61","lowerLimit":"1.24","upperLimit":"2.09"},{"groupId":"OG002","value":"0.97","lowerLimit":"0.88","upperLimit":"1.05"},{"groupId":"OG003","value":"1.58","lowerLimit":"1.35","upperLimit":"1.84"},{"groupId":"OG004","value":"1.72","lowerLimit":"1.45","upperLimit":"2.05"},{"groupId":"OG005","value":"1.25","lowerLimit":"1.11","upperLimit":"1.41"}]}]},{"title":"PspA-Fam1","categories":[{"measurements":[{"groupId":"OG000","value":"2.15","lowerLimit":"1.47","upperLimit":"3.14"},{"groupId":"OG001","value":"2.00","lowerLimit":"1.18","upperLimit":"3.38"},{"groupId":"OG002","value":"0.94","lowerLimit":"0.87","upperLimit":"1.02"},{"groupId":"OG003","value":"1.66","lowerLimit":"1.34","upperLimit":"2.04"},{"groupId":"OG004","value":"1.66","lowerLimit":"1.36","upperLimit":"2.03"},{"groupId":"OG005","value":"1.36","lowerLimit":"1.11","upperLimit":"1.67"}]}]},{"title":"PhtD","categories":[{"measurements":[{"groupId":"OG000","value":"1.14","lowerLimit":"0.96","upperLimit":"1.36"},{"groupId":"OG001","value":"0.98","lowerLimit":"0.82","upperLimit":"1.16"},{"groupId":"OG002","value":"0.98","lowerLimit":"0.91","upperLimit":"1.06"},{"groupId":"OG003","value":"1.30","lowerLimit":"1.11","upperLimit":"1.51"},{"groupId":"OG004","value":"1.49","lowerLimit":"1.31","upperLimit":"1.70"},{"groupId":"OG005","value":"1.20","lowerLimit":"1.07","upperLimit":"1.34"}]}]},{"title":"BCH0785","categories":[{"measurements":[{"groupId":"OG000","value":"1.20","lowerLimit":"1.02","upperLimit":"1.42"},{"groupId":"OG001","value":"1.14","lowerLimit":"0.77","upperLimit":"1.68"},{"groupId":"OG002","value":"0.97","lowerLimit":"0.90","upperLimit":"1.04"},{"groupId":"OG003","value":"1.38","lowerLimit":"1.15","upperLimit":"2.15"},{"groupId":"OG004","value":"1.87","lowerLimit":"1.53","upperLimit":"2.28"},{"groupId":"OG005","value":"1.18","lowerLimit":"1.06","upperLimit":"1.32"}]}]},{"title":"StkP","categories":[{"measurements":[{"groupId":"OG000","value":"1.34","lowerLimit":"1.10","upperLimit":"1.62"},{"groupId":"OG001","value":"1.32","lowerLimit":"0.98","upperLimit":"1.77"},{"groupId":"OG002","value":"0.99","lowerLimit":"0.92","upperLimit":"1.06"},{"groupId":"OG003","value":"1.80","lowerLimit":"1.51","upperLimit":"2.15"},{"groupId":"OG004","value":"1.87","lowerLimit":"1.53","upperLimit":"2.28"},{"groupId":"OG005","value":"1.18","lowerLimit":"1.06","upperLimit":"1.32"}]}]},{"title":"PcpA","categories":[{"measurements":[{"groupId":"OG000","value":"1.00","lowerLimit":"0.87","upperLimit":"1.14"},{"groupId":"OG001","value":"0.85","lowerLimit":"0.65","upperLimit":"1.11"},{"groupId":"OG002","value":"0.97","lowerLimit":"0.90","upperLimit":"1.05"},{"groupId":"OG003","value":"1.21","lowerLimit":"0.98","upperLimit":"1.49"},{"groupId":"OG004","value":"1.34","lowerLimit":"1.06","upperLimit":"1.70"},{"groupId":"OG005","value":"1.34","lowerLimit":"1.11","upperLimit":"1.61"}]}]},{"title":"SPWCV","categories":[{"measurements":[{"groupId":"OG000","value":"1.11","lowerLimit":"0.93","upperLimit":"1.33"},{"groupId":"OG001","value":"1.08","lowerLimit":"0.88","upperLimit":"1.32"},{"groupId":"OG002","value":"0.99","lowerLimit":"0.91","upperLimit":"1.07"},{"groupId":"OG003","value":"1.29","lowerLimit":"1.13","upperLimit":"1.47"},{"groupId":"OG004","value":"1.26","lowerLimit":"1.12","upperLimit":"1.43"},{"groupId":"OG005","value":"1.12","lowerLimit":"1.05","upperLimit":"1.20"}]}]},{"title":"PiuA","categories":[{"measurements":[{"groupId":"OG000","value":"1.52","lowerLimit":"1.17","upperLimit":"1.97"},{"groupId":"OG001","value":"1.32","lowerLimit":"0.84","upperLimit":"2.08"},{"groupId":"OG002","value":"0.99","lowerLimit":"0.93","upperLimit":"1.06"},{"groupId":"OG003","value":"1.35","lowerLimit":"1.12","upperLimit":"1.62"},{"groupId":"OG004","value":"1.46","lowerLimit":"1.22","upperLimit":"1.76"},{"groupId":"OG005","value":"1.11","lowerLimit":"0.98","upperLimit":"1.25"}]}]},{"title":"PiaA","categories":[{"measurements":[{"groupId":"OG000","value":"1.35","lowerLimit":"1.10","upperLimit":"1.65"},{"groupId":"OG001","value":"1.23","lowerLimit":"0.99","upperLimit":"1.54"},{"groupId":"OG002","value":"0.98","lowerLimit":"0.90","upperLimit":"1.08"},{"groupId":"OG003","value":"1.33","lowerLimit":"1.14","upperLimit":"1.55"},{"groupId":"OG004","value":"1.36","lowerLimit":"1.15","upperLimit":"1.62"},{"groupId":"OG005","value":"1.08","lowerLimit":"0.94","upperLimit":"1.24"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Immunoglobulin G (IgG) Seroresponse","description":"Between baseline and 28 days after vaccination 2. Proteins were measured on the Meso Scale Discovery (MSD) platform using an an electrochemiluminescence detection assay.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Baseline and 12 weeks after vaccination 2 (Day 0 and Day 112)","groups":[{"id":"OG000","title":"Adult 0.6mg PATH-wSP","description":"Two 0.6 mg doses of PATH-wSP with a 28 day interval between doses\n\nPATH-wSP: Streptococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide"},{"id":"OG001","title":"Adult 1.0 mg PATH-wSP","description":"Two 1 mg doses of PATH-wSP with a 28 day interval between doses\n\nPATH-wSP: Streptococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide"},{"id":"OG002","title":"Adult Placebo","description":"Two injections of normal saline with a 28 day interval between injections\n\nPlacebo: Normal Saline"},{"id":"OG003","title":"Toddler 0.6mg PATH-wSP","description":"Two 0.6 mg doses of PATH-wSP with a 28 day interval between doses\n\nPATH-wSP: Streptococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide"},{"id":"OG004","title":"Toddler 1.0 mg PATH-wSP","description":"Two 1 mg doses of PATH-wSP with a 28 day interval between doses\n\nPATH-wSP: Streptococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide"},{"id":"OG005","title":"Toddler Placebo","description":"Two injections of normal saline with a 28 day interval between injections\n\nPlacebo: Normal Saline"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"24"},{"groupId":"OG003","value":"50"},{"groupId":"OG004","value":"49"},{"groupId":"OG005","value":"98"}]}],"classes":[{"title":"L460D","categories":[{"title":"<2 fold rise","measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"24"},{"groupId":"OG003","value":"34"},{"groupId":"OG004","value":"33"},{"groupId":"OG005","value":"78"}]},{"title":"Between 2 and 3 fold rise","measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"12"},{"groupId":"OG004","value":"11"},{"groupId":"OG005","value":"13"}]},{"title":"Between 3 and 4 fold rise","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"6"}]},{"title":"≥4 fold rise","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"4"},{"groupId":"OG005","value":"1"}]}]},{"title":"PspA-Fam1","categories":[{"title":"<2 fold rise","measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"24"},{"groupId":"OG003","value":"31"},{"groupId":"OG004","value":"30"},{"groupId":"OG005","value":"72"}]},{"title":"Between 2 and 3 fold rise","measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"11"},{"groupId":"OG004","value":"12"},{"groupId":"OG005","value":"6"}]},{"title":"Between 3 and 4 fold rise","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"5"},{"groupId":"OG004","value":"3"},{"groupId":"OG005","value":"2"}]},{"title":"≥4 fold rise","measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"3"},{"groupId":"OG004","value":"4"},{"groupId":"OG005","value":"18"}]}]},{"title":"PhtD","categories":[{"title":"<2 fold rise","measurements":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"24"},{"groupId":"OG003","value":"37"},{"groupId":"OG004","value":"39"},{"groupId":"OG005","value":"78"}]},{"title":"Between 2 and 3 fold rise","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"11"},{"groupId":"OG004","value":"4"},{"groupId":"OG005","value":"17"}]},{"title":"Between 3 and 4 fold rise","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"6"},{"groupId":"OG005","value":"2"}]},{"title":"≥4 fold rise","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"1"}]}]},{"title":"BCH0785","categories":[{"title":"<2 fold rise","measurements":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"24"},{"groupId":"OG003","value":"36"},{"groupId":"OG004","value":"33"},{"groupId":"OG005","value":"81"}]},{"title":"Between 2 and 3 fold rise","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"7"},{"groupId":"OG004","value":"6"},{"groupId":"OG005","value":"6"}]},{"title":"Between 3 and 4 fold rise","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"4"},{"groupId":"OG004","value":"4"},{"groupId":"OG005","value":"5"}]},{"title":"≥4 fold rise","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"3"},{"groupId":"OG004","value":"6"},{"groupId":"OG005","value":"6"}]}]},{"title":"StkP","categories":[{"title":"<2 fold rise","measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"24"},{"groupId":"OG003","value":"25"},{"groupId":"OG004","value":"27"},{"groupId":"OG005","value":"78"}]},{"title":"Between 2 and 3 fold rise","measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"16"},{"groupId":"OG004","value":"12"},{"groupId":"OG005","value":"15"}]},{"title":"Between 3 and 4 fold rise","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"5"},{"groupId":"OG005","value":"3"}]},{"title":"≥4 fold rise","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"8"},{"groupId":"OG004","value":"5"},{"groupId":"OG005","value":"2"}]}]},{"title":"PcpA","categories":[{"title":"<2 fold rise","measurements":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"24"},{"groupId":"OG003","value":"44"},{"groupId":"OG004","value":"33"},{"groupId":"OG005","value":"69"}]},{"title":"Between 2 and 3 fold rise","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"7"},{"groupId":"OG005","value":"13"}]},{"title":"Between 3 and 4 fold rise","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"3"},{"groupId":"OG004","value":"5"},{"groupId":"OG005","value":"7"}]},{"title":"≥4 fold rise","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"4"},{"groupId":"OG005","value":"9"}]}]},{"title":"SPWCV","categories":[{"title":"<2 fold rise","measurements":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"24"},{"groupId":"OG003","value":"43"},{"groupId":"OG004","value":"45"},{"groupId":"OG005","value":"95"}]},{"title":"Between 2 and 3 fold rise","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"6"},{"groupId":"OG004","value":"2"},{"groupId":"OG005","value":"3"}]},{"title":"Between 3 and 4 fold rise","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}]},{"title":"≥4 fold rise","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}]}]},{"title":"PiuA","categories":[{"title":"<2 fold rise","measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"24"},{"groupId":"OG003","value":"40"},{"groupId":"OG004","value":"37"},{"groupId":"OG005","value":"82"}]},{"title":"Between 2 and 3 fold rise","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"6"},{"groupId":"OG004","value":"6"},{"groupId":"OG005","value":"11"}]},{"title":"Between 3 and 4 fold rise","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"3"},{"groupId":"OG005","value":"4"}]},{"title":"≥4 fold rise","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"4"},{"groupId":"OG004","value":"3"},{"groupId":"OG005","value":"1"}]}]},{"title":"PiaA","categories":[{"title":"<2 fold rise","measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"24"},{"groupId":"OG003","value":"43"},{"groupId":"OG004","value":"38"},{"groupId":"OG005","value":"89"}]},{"title":"Between 2 and 3 fold rise","measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"3"},{"groupId":"OG004","value":"5"},{"groupId":"OG005","value":"3"}]},{"title":"Between 3 and 4 fold rise","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"4"},{"groupId":"OG005","value":"4"}]},{"title":"≥4 fold rise","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"3"},{"groupId":"OG004","value":"2"},{"groupId":"OG005","value":"2"}]}]}]},{"type":"PRIMARY","title":"Number of Adverse Events (AE), by Relation to Vaccine and Seriousness","description":"Only treatment-emergent adverse events (TEAEs) were included in the analysis; adverse events (AEs) that were not TEAEs were to have been listed.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"adverse events","timeFrame":"112 days","groups":[{"id":"OG000","title":"Adult 0.6mg PATH-wSP","description":"Two 0.6 mg doses of PATH-wSP with a 28 day interval between doses\n\nPATH-wSP: Streptococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide"},{"id":"OG001","title":"Adult 1.0 mg PATH-wSP","description":"Two 1 mg doses of PATH-wSP with a 28 day interval between doses\n\nPATH-wSP: Streptococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide"},{"id":"OG002","title":"Adult Placebo","description":"Two injections of normal saline with a 28 day interval between injections\n\nPlacebo: Normal Saline"},{"id":"OG003","title":"Toddler 0.6mg PATH-wSP","description":"Two 0.6 mg doses of PATH-wSP with a 28 day interval between doses\n\nPATH-wSP: Streptococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide"},{"id":"OG004","title":"Toddler 1.0 mg PATH-wSP","description":"Two 1 mg doses of PATH-wSP with a 28 day interval between doses\n\nPATH-wSP: Streptococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide"},{"id":"OG005","title":"Toddler Placebo","description":"Two injections of normal saline with a 28 day interval between injections\n\nPlacebo: Normal Saline"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"12"},{"groupId":"OG002","value":"24"},{"groupId":"OG003","value":"50"},{"groupId":"OG004","value":"50"},{"groupId":"OG005","value":"100"}]}],"classes":[{"title":"Serious : Related","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"2"}]}]},{"title":"Serious : Not related","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"3"},{"groupId":"OG004","value":"2"},{"groupId":"OG005","value":"3"}]}]},{"title":"Non-serious : Related","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"2"},{"groupId":"OG005","value":"1"}]}]},{"title":"Non-serious : Not related","categories":[{"measurements":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"21"},{"groupId":"OG002","value":"39"},{"groupId":"OG003","value":"148"},{"groupId":"OG004","value":"80"},{"groupId":"OG005","value":"253"}]}]}]}]},"adverseEventsModule":{"frequencyThreshold":"0","timeFrame":"112 days from receipt of first vaccination","eventGroups":[{"id":"EG000","title":"Adult 0.6mg PATH-wSP","description":"Two 0.6 mg doses of PATH-wSP with a 28 day interval between doses\n\nPATH-wSP: Streptococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide","deathsNumAffected":0,"deathsNumAtRisk":12,"seriousNumAffected":0,"seriousNumAtRisk":12,"otherNumAffected":9,"otherNumAtRisk":12},{"id":"EG001","title":"Adult 1.0 mg PATH-wSP","description":"Two 1 mg doses of PATH-wSP with a 28 day interval between doses\n\nPATH-wSP: Streptococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide","deathsNumAffected":0,"deathsNumAtRisk":12,"seriousNumAffected":0,"seriousNumAtRisk":12,"otherNumAffected":9,"otherNumAtRisk":12},{"id":"EG002","title":"Adult Placebo","description":"Two injections of normal saline with a 28 day interval between injections\n\nPlacebo: Normal Saline","deathsNumAffected":0,"deathsNumAtRisk":24,"seriousNumAffected":0,"seriousNumAtRisk":24,"otherNumAffected":20,"otherNumAtRisk":24},{"id":"EG003","title":"Toddler 0.6mg PATH-wSP","description":"Two 0.6 mg doses of PATH-wSP with a 28 day interval between doses\n\nPATH-wSP: Streptococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide","deathsNumAffected":0,"deathsNumAtRisk":50,"seriousNumAffected":2,"seriousNumAtRisk":50,"otherNumAffected":45,"otherNumAtRisk":50},{"id":"EG004","title":"Toddler 1.0 mg PATH-wSP","description":"Two 1 mg doses of PATH-wSP with a 28 day interval between doses\n\nPATH-wSP: Streptococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide","deathsNumAffected":0,"deathsNumAtRisk":50,"seriousNumAffected":1,"seriousNumAtRisk":50,"otherNumAffected":44,"otherNumAtRisk":50},{"id":"EG005","title":"Toddler Placebo","description":"Two injections of normal saline with a 28 day interval between injections\n\nPlacebo: Normal Saline","deathsNumAffected":0,"deathsNumAtRisk":100,"seriousNumAffected":5,"seriousNumAtRisk":100,"otherNumAffected":87,"otherNumAtRisk":100}],"seriousEvents":[{"term":"Pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":1,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":2,"numAtRisk":100}]},{"term":"Bronchial hyperreactivity","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":1,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":1,"numAtRisk":100}]},{"term":"Gastroenteritis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":1,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":1,"numAtRisk":100}]},{"term":"Malaria","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":1,"numAtRisk":50},{"groupId":"EG005","numAffected":1,"numAtRisk":100}]},{"term":"Febrile convulsion","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":1,"numAtRisk":50},{"groupId":"EG005","numAffected":2,"numAtRisk":100}]},{"term":"Pneumococcal bacteremia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":1,"numAtRisk":100}]}],"otherEvents":[{"term":"Upper respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":12},{"groupId":"EG001","numAffected":4,"numAtRisk":12},{"groupId":"EG002","numAffected":9,"numAtRisk":24},{"groupId":"EG003","numAffected":27,"numAtRisk":50},{"groupId":"EG004","numAffected":3,"numAtRisk":50},{"groupId":"EG005","numAffected":23,"numAtRisk":100}]},{"term":"Gastroenteritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":12},{"groupId":"EG001","numAffected":2,"numAtRisk":12},{"groupId":"EG002","numAffected":1,"numAtRisk":24},{"groupId":"EG003","numAffected":11,"numAtRisk":50},{"groupId":"EG004","numAffected":2,"numAtRisk":50},{"groupId":"EG005","numAffected":11,"numAtRisk":100}]},{"term":"Tonsillitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":12},{"groupId":"EG001","numAffected":1,"numAtRisk":12},{"groupId":"EG002","numAffected":2,"numAtRisk":24},{"groupId":"EG003","numAffected":3,"numAtRisk":50},{"groupId":"EG004","numAffected":4,"numAtRisk":50},{"groupId":"EG005","numAffected":7,"numAtRisk":100}]},{"term":"Conjunctivitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":1,"numAtRisk":12},{"groupId":"EG002","numAffected":2,"numAtRisk":24},{"groupId":"EG003","numAffected":3,"numAtRisk":50},{"groupId":"EG004","numAffected":6,"numAtRisk":50},{"groupId":"EG005","numAffected":8,"numAtRisk":100}]},{"term":"Malaria","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":2,"numAtRisk":24},{"groupId":"EG003","numAffected":3,"numAtRisk":50},{"groupId":"EG004","numAffected":1,"numAtRisk":50},{"groupId":"EG005","numAffected":6,"numAtRisk":100}]},{"term":"Rhinitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":1,"numAtRisk":12},{"groupId":"EG002","numAffected":1,"numAtRisk":24},{"groupId":"EG003","numAffected":20,"numAtRisk":50},{"groupId":"EG004","numAffected":23,"numAtRisk":50},{"groupId":"EG005","numAffected":47,"numAtRisk":100}]},{"term":"Urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":12},{"groupId":"EG001","numAffected":1,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":1,"numAtRisk":100}]},{"term":"Body tinea","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":3,"numAtRisk":50},{"groupId":"EG004","numAffected":3,"numAtRisk":50},{"groupId":"EG005","numAffected":11,"numAtRisk":100}]},{"term":"Cellulitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":1,"numAtRisk":24},{"groupId":"EG003","numAffected":1,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":2,"numAtRisk":100}]},{"term":"Helminthic infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":1,"numAtRisk":50},{"groupId":"EG005","numAffected":4,"numAtRisk":100}]},{"term":"Mastitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":1,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":0,"numAtRisk":100}]},{"term":"Onychomycosis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":1,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":0,"numAtRisk":100}]},{"term":"Pelvic inflammatory disease","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":1,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":0,"numAtRisk":100}]},{"term":"Pharyngitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":1,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":0,"numAtRisk":100}]},{"term":"Urethritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":0,"numAtRisk":100}]},{"term":"Wound sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":1,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":0,"numAtRisk":100}]},{"term":"Rash pustular","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":13,"numAtRisk":50},{"groupId":"EG004","numAffected":7,"numAtRisk":50},{"groupId":"EG005","numAffected":11,"numAtRisk":100}]},{"term":"Tinea capitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":3,"numAtRisk":50},{"groupId":"EG004","numAffected":1,"numAtRisk":50},{"groupId":"EG005","numAffected":5,"numAtRisk":100}]},{"term":"Pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":2,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":0,"numAtRisk":100}]},{"term":"Varicella","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":1,"numAtRisk":50},{"groupId":"EG004","numAffected":2,"numAtRisk":50},{"groupId":"EG005","numAffected":3,"numAtRisk":100}]},{"term":"Otitis media","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":3,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":2,"numAtRisk":100}]},{"term":"Subcutaneous abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":2,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":3,"numAtRisk":100}]},{"term":"Otitis media acute","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":1,"numAtRisk":50},{"groupId":"EG005","numAffected":3,"numAtRisk":100}]},{"term":"Abscess limb","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":1,"numAtRisk":50},{"groupId":"EG005","numAffected":0,"numAtRisk":100}]},{"term":"Abscess neck","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":1,"numAtRisk":100}]},{"term":"Abscess of eyelid","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":1,"numAtRisk":100}]},{"term":"Acarodermatitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":1,"numAtRisk":100}]},{"term":"Bronchiolitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":1,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":0,"numAtRisk":100}]},{"term":"Dermatitis infected","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":1,"numAtRisk":100}]},{"term":"Dysentery","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":1,"numAtRisk":100}]},{"term":"Febrile infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":1,"numAtRisk":100}]},{"term":"Furuncle","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":1,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":0,"numAtRisk":100}]},{"term":"Impetigo","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":1,"numAtRisk":100}]},{"term":"Oral candidiasis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":1,"numAtRisk":100}]},{"term":"Otitis externa","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":1,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":0,"numAtRisk":100}]},{"term":"Septic rash","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":1,"numAtRisk":100}]},{"term":"Skin infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":1,"numAtRisk":100}]},{"term":"Tinea infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":1,"numAtRisk":50},{"groupId":"EG005","numAffected":0,"numAtRisk":100}]},{"term":"Dental caries","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":12},{"groupId":"EG001","numAffected":1,"numAtRisk":12},{"groupId":"EG002","numAffected":2,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":0,"numAtRisk":100}]},{"term":"Toothache","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":2,"numAtRisk":12},{"groupId":"EG002","numAffected":1,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":0,"numAtRisk":100}]},{"term":"Abdominal Pain","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":2,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":0,"numAtRisk":100}]},{"term":"Gastritis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":1,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":0,"numAtRisk":100}]},{"term":"Diarrhoea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":13,"numAtRisk":50},{"groupId":"EG004","numAffected":6,"numAtRisk":50},{"groupId":"EG005","numAffected":20,"numAtRisk":100}]},{"term":"Stomatitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":1,"numAtRisk":50},{"groupId":"EG005","numAffected":2,"numAtRisk":100}]},{"term":"Back pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":2,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":0,"numAtRisk":100}]},{"term":"Myalgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":1,"numAtRisk":12},{"groupId":"EG002","numAffected":1,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":0,"numAtRisk":100}]},{"term":"Arthritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":1,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":0,"numAtRisk":100}]},{"term":"Exostosis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":1,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":0,"numAtRisk":100}]},{"term":"Headache","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":12},{"groupId":"EG001","numAffected":2,"numAtRisk":12},{"groupId":"EG002","numAffected":1,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":0,"numAtRisk":100}]},{"term":"Febrile convulsion","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":1,"numAtRisk":100}]},{"term":"Soft tissue injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":1,"numAtRisk":12},{"groupId":"EG002","numAffected":1,"numAtRisk":24},{"groupId":"EG003","numAffected":1,"numAtRisk":50},{"groupId":"EG004","numAffected":2,"numAtRisk":50},{"groupId":"EG005","numAffected":2,"numAtRisk":100}]},{"term":"Thermal burn","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":1,"numAtRisk":50},{"groupId":"EG004","numAffected":2,"numAtRisk":50},{"groupId":"EG005","numAffected":4,"numAtRisk":100}]},{"term":"Skin wound","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":2,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":1,"numAtRisk":100}]},{"term":"Limb injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":2,"numAtRisk":100}]},{"term":"Skin injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":1,"numAtRisk":50},{"groupId":"EG005","numAffected":2,"numAtRisk":100}]},{"term":"Greenstick fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":1,"numAtRisk":50},{"groupId":"EG005","numAffected":0,"numAtRisk":100}]},{"term":"Wound","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":1,"numAtRisk":100}]},{"term":"Fatigue","organSystem":"General disorders","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":0,"numAtRisk":100}]},{"term":"Vaccination site pain","organSystem":"General disorders","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":1,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":0,"numAtRisk":100}]},{"term":"Pyrexia","organSystem":"General disorders","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":2,"numAtRisk":50},{"groupId":"EG004","numAffected":7,"numAtRisk":50},{"groupId":"EG005","numAffected":13,"numAtRisk":100}]},{"term":"Vaccination site induration","organSystem":"General disorders","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":2,"numAtRisk":50},{"groupId":"EG005","numAffected":0,"numAtRisk":100}]},{"term":"Vaccination site swelling","organSystem":"General disorders","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":1,"numAtRisk":100}]},{"term":"Dysmenorrhoea","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":1,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":0,"numAtRisk":100}]},{"term":"Menorrhagia","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":1,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":0,"numAtRisk":100}]},{"term":"Balanoposthitis","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":1,"numAtRisk":100}]},{"term":"Dermatitis","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":1,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":0,"numAtRisk":100}]},{"term":"Rash papular","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":1,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":1,"numAtRisk":100}]},{"term":"Rash vesicular","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":3,"numAtRisk":100}]},{"term":"Dermatitis allergic","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":1,"numAtRisk":50},{"groupId":"EG005","numAffected":0,"numAtRisk":100}]},{"term":"Urticaria papular","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":1,"numAtRisk":100}]},{"term":"Cough","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":1,"numAtRisk":24},{"groupId":"EG003","numAffected":1,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":0,"numAtRisk":100}]},{"term":"Bronchial hyperreactivity","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":1,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":0,"numAtRisk":100}]},{"term":"Bronchospasm","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":1,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":0,"numAtRisk":100}]},{"term":"Epistaxis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":1,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":0,"numAtRisk":100}]},{"term":"Hepatitis acute","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":0,"numAtRisk":50},{"groupId":"EG005","numAffected":1,"numAtRisk":100}]},{"term":"White blood cell count increased","organSystem":"Investigations","sourceVocabulary":"MedDRA (21.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12},{"groupId":"EG001","numAffected":0,"numAtRisk":12},{"groupId":"EG002","numAffected":0,"numAtRisk":24},{"groupId":"EG003","numAffected":0,"numAtRisk":50},{"groupId":"EG004","numAffected":1,"numAtRisk":50},{"groupId":"EG005","numAffected":0,"numAtRisk":100}]}]},"moreInfoModule":{"certainAgreement":{"piSponsorEmployee":false,"restrictiveAgreement":false},"pointOfContact":{"title":"Jorge Flores","organization":"PATH","email":"jeflores@path.org","phone":"(202) 822-0033"}}},"documentSection":{"largeDocumentModule":{"largeDocs":[{"typeAbbrev":"Prot","hasProtocol":true,"hasSap":false,"hasIcf":false,"label":"Study Protocol","date":"2017-11-03","uploadDate":"2018-08-31T09:02","filename":"Prot_000.pdf","size":3041523},{"typeAbbrev":"SAP","hasProtocol":false,"hasSap":true,"hasIcf":false,"label":"Statistical Analysis Plan","date":"2018-01-11","uploadDate":"2018-08-31T09:03","filename":"SAP_001.pdf","size":1577739}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2026-11-09"},"conditionBrowseModule":{"meshes":[{"id":"D011014","term":"Pneumonia"}],"ancestors":[{"id":"D012141","term":"Respiratory Tract Infections"},{"id":"D007239","term":"Infections"},{"id":"D008171","term":"Lung Diseases"},{"id":"D012140","term":"Respiratory Tract Diseases"}]}},"hasResults":true}